IDEAYA Biosciences
IDYA
24 hedge funds and large institutions have $49.5M invested in IDEAYA Biosciences in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 24 → 24 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
1.58% less ownership
Funds ownership: 29.02% → 27.44% (-1.6%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
43% less capital inflows, than outflows
Capital inflows: $1.14M | Capital outflows: $1.99M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bridgeway Capital Management
Houston,
Texas
|
+$382K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$334K |
| 3 |
Millennium Management
New York
|
+$142K |
| 4 |
Squarepoint
New York
|
+$100K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$78.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIM
DC Investments Management
Mclean,
Virginia
|
-$534K |
| 2 |
BVF Inc
San Francisco,
California
|
-$488K |
| 3 |
Goldman Sachs
New York
|
-$425K |
| 4 |
Monashee Investment Management
Boston,
Massachusetts
|
-$354K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$100K |
IDYA Hedge Fund Activity: Q3 2019 in Review
24 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2019, worth a combined $49.5M — down 12% from $56.3M a quarter earlier.
Fund positioning in IDYA was balanced in Q3 2019: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 7 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $382K. The largest seller was DC Investments Management, exiting entirely with an estimated $534K sold.
- 24 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $49.5M of IDEAYA Biosciences stock for Q3 2019, down 12% quarter-over-quarter.
- 4 funds opened new IDEAYA Biosciences positions in Q3 2019 and 4 closed out, a net change of 0 holders.
- The largest IDEAYA Biosciences buyer in Q3 2019 was Bridgeway Capital Management, an estimated $382K added.
- The largest IDEAYA Biosciences seller in Q3 2019 was DC Investments Management, an estimated $534K sold.
Based on aggregated 13F filings for Q3 2019.